| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/05/2007 | CA2110938C Modified proteins containing controllable intervening sequences and methods of their production |
| 06/02/2007 | CA2632245A1 Novel plant virus particles and methods of inactivation thereof |
| 05/31/2007 | WO2007062359A1 Methods and reagents for elimination or reduction of false positives in the analysis of a sample |
| 05/31/2007 | WO2007062188A2 Activin-actriia antagonists and uses for promoting bone growth |
| 05/31/2007 | WO2007062150A2 Leukotoxin compositions and therapeutic methods |
| 05/31/2007 | WO2007062101A2 Intraocular pressure-regulated early genes and uses thereof |
| 05/31/2007 | WO2007061762A2 Non-viral gene delivery complex |
| 05/31/2007 | WO2007061690A2 Novel pharmaceutical compositions for the treatment of virus infection and cancer |
| 05/31/2007 | WO2007061631A2 Production of glycoproteins with reduced o-glycosylation |
| 05/31/2007 | WO2007061292A1 Uses of the fcrn receptor |
| 05/31/2007 | WO2007061141A1 Mutant paramyxovirus and method for production thereof |
| 05/31/2007 | WO2007060899A1 Application of actin-binding protein to disease associated with cell motility |
| 05/31/2007 | WO2007060548A2 Chimeric, hybrid and tandem polypeptides of meningococcal nmb1870 |
| 05/31/2007 | WO2007060546A2 Characterization of novel lpxtg-containing proteins of staphylococcus epidermidis |
| 05/31/2007 | WO2007060514A2 Methods and compositions for modulating root growth in plants |
| 05/31/2007 | WO2007060431A1 Netrin-like (ntr) domain containing protein |
| 05/31/2007 | WO2007060425A1 Thrombospondin domain-containing cell surface recognition molecules |
| 05/31/2007 | WO2007060423A1 Signal anchored protein |
| 05/31/2007 | WO2007060411A1 Anti-tnf alpha antibodies which selectively inhibit tnf alpha signalling through the p55r |
| 05/31/2007 | WO2007060406A1 Bioassays |
| 05/31/2007 | WO2007060240A2 Method for demonstrating presence or absence of markers (eef1a1 or mark3 )associated with the presence and/or the chemosensitivity of tumors |
| 05/31/2007 | WO2007060213A2 Erythropoietin polypeptides and uses thereof |
| 05/31/2007 | WO2007060119A1 Production and use of highly functional, highly branched or hyperbranched polylysines |
| 05/31/2007 | WO2007060117A2 Chimeric keratin-binding effector proteins |
| 05/31/2007 | WO2007059852A1 Ph-switchable transmembrane peptides as stimulators of membrane fusion |
| 05/31/2007 | WO2007059715A2 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses |
| 05/31/2007 | WO2007059714A1 Neuropeptides for the culture of aquatic organisms |
| 05/31/2007 | WO2007059612A1 Novel stem cells, nucleotide sequences and proteins therefrom |
| 05/31/2007 | WO2007059597A2 Accelerated angiogenesis-inducing protein, compositions inducing accelerated angiogenesis and uses thereof |
| 05/31/2007 | WO2007059574A1 A molecule and chimeric molecules thereof |
| 05/31/2007 | WO2007042524A3 Treating diabetes using inhibitors of il-1 |
| 05/31/2007 | WO2007042487A3 Use of proteins as an antifoaming constituent in fuels |
| 05/31/2007 | WO2007042169A3 Matrix metalloproteinase 11 vaccine |
| 05/31/2007 | WO2007041439A9 Centrosomal proteins, nucleic acids and method of use thereof |
| 05/31/2007 | WO2007039254A3 Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia |
| 05/31/2007 | WO2007038386A8 Method for enhancing immune responses in mammals |
| 05/31/2007 | WO2007036299A3 Method for amidating polypeptides with basic aminoacid c- terminals by means of specific endoproteases |
| 05/31/2007 | WO2007030693A3 Methods for promoting stem cell proliferation and survival |
| 05/31/2007 | WO2007028632A3 Analogs of gastric inhibitory polypeptide as a treatment for age related decreased pancreatic beta cell function |
| 05/31/2007 | WO2007025276A3 Use of hiv envelope/ cd4 complexes as immunogenic complexes for the generation of antibodies |
| 05/31/2007 | WO2007018583A3 Human growth hormone conjugated with biocompatible polymer |
| 05/31/2007 | WO2007006025A3 Lefty, lefty derivatives and uses therof |
| 05/31/2007 | WO2007005934A3 Constrained hiv envelope-based immunogen that simultaneously presents receptor and coreceptor binding sites |
| 05/31/2007 | WO2006136607A3 Use of hydrophobin-polypeptides and conjugates from hydrophobin-polypeptides having active and effect agents and the production thereof and use thereof in the cosmetic industry |
| 05/31/2007 | WO2006135930A3 Transmucosal delivery of peptide derivatives |
| 05/31/2007 | WO2006133457A3 Bone morphogenetic variants, compositions and methods of treatment |
| 05/31/2007 | WO2006124013A3 Novel stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof, and method of use |
| 05/31/2007 | WO2006117582A3 Export of recombinant proteins by flagellar export apparatus |
| 05/31/2007 | WO2006113214A3 Vaccine against pandemic strains of influenza viruses |
| 05/31/2007 | WO2006091672A3 Novel assays utilizing nicotinic acetylcholine receptor subunits |
| 05/31/2007 | WO2006091219A3 Methods of protecting plants from pathogenic fungi |
| 05/31/2007 | WO2006057832A3 Cytokinin-sensing histidine kinases and methods of use |
| 05/31/2007 | WO2006031353A3 Vascular endothelial growth factor fusion constructs and uses thereof |
| 05/31/2007 | WO2005117940A3 Cell death modulation via antagonists of fasl and fas activation |
| 05/31/2007 | WO2005070138A3 O-linked glycosylation of peptides |
| 05/31/2007 | WO2005058930A3 Methods for production of recombinant vascular endothelial cell growth inhibitor |
| 05/31/2007 | WO2005048918A3 Anthrax vaccine |
| 05/31/2007 | WO2005003316A3 Rna processing protein complexes and uses thereof |
| 05/31/2007 | US20070124838 Expression of the human igf-1 in transgenic plastids |
| 05/31/2007 | US20070124830 Plastid genetic engineering via somatic embryogenesis |
| 05/31/2007 | US20070124825 Use of hepcidin as a regulator of iron homeostasis |
| 05/31/2007 | US20070123699 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 05/31/2007 | US20070123698 Process for purification of hemoglobin |
| 05/31/2007 | US20070123697 purification from a recombinant human interferon beta-containing culture by performing affinity chromatography and reversed-phase high-performance liquid chromatography |
| 05/31/2007 | US20070123696 G-csf conjugates |
| 05/31/2007 | US20070123551 Use of metabotropic glutamarate receptor 5 (mglur5) antagonists for the treatment of gastrointestinal disorders |
| 05/31/2007 | US20070123486 Composition for coordinated VEGF and PDGF expression, and methods of use |
| 05/31/2007 | US20070123465 Oligomeric peptides and their use for the treatment of hiv infections |
| 05/31/2007 | US20070123460 Probiotic compounds from Lactobacillus GG and uses therefor |
| 05/31/2007 | US20070123459 IL-17 like molecules and uses thereof |
| 05/31/2007 | US20070123458 homodimeric disintegrins as biodrugs; modulate the adhesion, motility, and invasiveness of integrin expressing tumor cells; anticoagulant, antitumor, and anticarcinogenic agents |
| 05/31/2007 | US20070123457 Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof |
| 05/31/2007 | US20070123456 Novel regulator of endothelial cell function and vessel remodeling |
| 05/31/2007 | US20070123455 Immunomodulatory agents for treatment of inflammatory diseases |
| 05/31/2007 | US20070122895 Genetic engineered polypeptide with specific amino acid sequence, to identify a secretory signal sequence native to Pichia methanolica to enable the use of methylotrophic yeasts for production of polypeptides |
| 05/31/2007 | US20070122887 Gene variants coding for proteins from the metabolic pathway of fine chemicals |
| 05/31/2007 | US20070122884 Factor VII glycoforms |
| 05/31/2007 | US20070122883 Nucleotide sequences coding orphan receptor component of multimeric complex for use in identifying modulator for prevention and treatment of cell proliferative disorders |
| 05/31/2007 | US20070122882 Gene specifically expressed in postmitotic dopaminergic neuron precursor cells |
| 05/31/2007 | US20070122880 Vector for the inducible expression of gene sequences |
| 05/31/2007 | US20070122879 for detecting and treating viral infections in in vitro and in vivo; ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo; for forming a heterodimeric receptor complex with IL-28R and CRF2-4 |
| 05/31/2007 | US20070122878 Human orphan G protein-coupled receptors |
| 05/31/2007 | US20070122868 Drug screening; identifying potential biological targets for fungicides and for isolating genes coding for proteins controlling biochemical functions essential to the pathogenesis of the fungus Magnaporthe grisea with respect to rice and barley |
| 05/31/2007 | US20070122859 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD |
| 05/31/2007 | US20070122858 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
| 05/31/2007 | US20070122853 Methods and compositions for detecting larval Taenia solium with a cloned diagnostic antigen |
| 05/31/2007 | US20070122851 Novel fluorescent and colored proteins, and polynucleotides that encode these proteins |
| 05/31/2007 | US20070122849 Rhesus monkey P2X7 purinergic receptor and uses thereof |
| 05/31/2007 | US20070122836 Transforming growth factor (TGF); determining the presence or absence of a lesion in a specimen which is characterized by a alteration in the the nucleotide or amino acid sequence; polymerase chain reaction; used in diagnosing cancer |
| 05/31/2007 | US20070122832 Process for Preparing L-amino Acids |
| 05/31/2007 | US20070122810 Brain tumor marker and method of diagnosing brain tumor |
| 05/31/2007 | US20070122807 Posh polypeptides, complexes and related methods |
| 05/31/2007 | US20070122434 Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus |
| 05/31/2007 | US20070122428 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 05/31/2007 | US20070122427 Delivery of trefoil peptides |
| 05/31/2007 | US20070122425 fusion protein comprising a periplasmic targeting signal and at least one antimicrobial peptide; use as microbiocides; from Gram negative bacteria transformed host cell; nontoxic and proteolytic non-degradation, simple, inexpensive recovery of the peptide; industrial scale production; on medical devices |
| 05/31/2007 | US20070122423 Derp1 and proderp1 allergen derivatives |
| 05/31/2007 | US20070122422 Sodium-independent small neutral amino acid transporter transporting L- and D- amino acids |
| 05/31/2007 | US20070122421 Flagellin fusion for use in generating vaccines for prevention and treatment of tumors, allergens and nervous system disorders |
| 05/31/2007 | US20070122412 Eg-vegf nucleic acids and polypeptides and methods of use |